Top

Diabetologia

Published in:

01-05-2014 | Article

Adiponectin reduces thermogenesis by inhibiting brown adipose tissue activation in mice

Authors: Liping Qiao, Hyung sun Yoo, Chris Bosco, Bonggi Lee, Gen-Sheng Feng, Jerome Schaack, Nai-Wen Chi, Jianhua Shao

Published in: Diabetologia | Issue 5/2014

Abstract

Aims/hypothesis

Adiponectin is an adipocyte-derived hormone that plays an important role in energy homeostasis. The main objective of this study was to investigate whether or not adiponectin regulates brown adipose tissue (BAT) activation and thermogenesis.

Methods

Core body temperatures (CBTs) of genetic mouse models were monitored at room temperature and during cold exposure. Cultured brown adipocytes and viral vector-mediated gene transduction were used to study the regulatory effects of adiponectin on Ucp1 gene expression and the underlying mechanisms.

Results

The CBTs of adiponectin knockout mice (Adipoq ^−/−) were significantly higher than those of wild type (WT) mice both at room temperature and during the cold (4°C) challenge. Conversely, reconstitution of adiponectin in Adipoq ^−/− mice significantly blunted β adrenergic receptor agonist-induced thermogenesis of interscapular BAT. After 10 days of intermittent cold exposure, Adipoq ^−/− mice exhibited higher UCP1 expression and more brown-like structure in inguinal fat than WT mice. Paradoxically, we found that the anti-thermogenic effect of adiponectin requires neither AdipoR1 nor AdipoR2, two well-known adiponectin receptors. In sharp contrast to the anti-thermogenic effects of adiponectin, AdipoR1 and especially AdipoR2 promote BAT activation. Mechanistically, adiponectin was found to inhibit Ucp1 gene expression by suppressing β₃-adrenergic receptor expression in brown adipocytes.

Conclusions/interpretation

This study demonstrates that adiponectin suppresses thermogenesis, which is likely to be a mechanism whereby adiponectin reduces energy expenditure.

Available only for authorised users

Nedergaard J, Bengtsson T, Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293:E444–E452PubMedCrossRef

Cypess AM, Lehman S, Williams G et al (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509–1517PubMedCentralPubMedCrossRef

Virtanen KA, Lidell ME, Orava J et al (2009) Functional brown adipose tissue in healthy adults. N Engl J Med 360:1518–1525PubMedCrossRef

van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM et al (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360:1500–1508PubMedCrossRef

Saito M, Okamatsu-Ogura Y, Matsushita M (2009) High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58:1526–1531PubMedCentralPubMedCrossRef

Feldmann HM, Golozoubova V, Cannon B, Nedergaard J (2009) UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 9:203–209PubMedCrossRef

Virtanen KA, Nuutila P (2011) Brown adipose tissue in humans. Curr Opin Lipidol 22:49–54PubMedCrossRef

Boström P, Wu J, Jedrychowski MP et al (2012) A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468PubMedCentralPubMedCrossRef

Cinti S (2002) Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ. J Endocrinol Invest 25:823–835PubMedCrossRef

10.

Fisher FM, Kleiner S, Douris N et al (2012) FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 26:271–281PubMedCentralPubMedCrossRef

11.

Ohno H, Shinoda K, Spiegelman BM, Kajimura S (2012) PPARγ agonists induce a white-to-brown fat conversion through stabilization of PRDM16 protein. Cell Metab 15:395–404PubMedCentralPubMedCrossRef

12.

Kim J-Y, van de Wall E, Laplante M et al (2007) Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117:2621–2637PubMedCentralPubMedCrossRef

13.

Kubota N, Yano W, Kubota T et al (2007) Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6:55–68PubMedCrossRef

14.

Saito K, Arata S, Hosono T et al (2006) Adiponectin plays an important role in efficient energy usage under energy shortage. Biochim Biophys Acta 1761:709–716PubMedCrossRef

15.

Kajimura D, Lee HW, Riley KJ et al (2013) Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab 17:901–915PubMedCrossRef

16.

Combs TP, Pajvani UB, Berg AH et al (2004) A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145:367–383PubMedCrossRef

17.

Qiao L, Kinney B, Schaack J, Shao J (2011) Adiponectin inhibits lipolysis in mouse adipocytes. Diabetes 60:1519–1527PubMedCentralPubMedCrossRef

18.

Wedellová Z, Dietrich J, Siklová-Vítková M et al (2011) Adiponectin inhibits spontaneous and catecholamine-induced lipolysis in human adipocytes of non-obese subjects through AMPK-dependent mechanisms. Physiol Res 60:139–148PubMed

19.

Dong M, Yang X, Lim S et al (2013) Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab 18:118–129PubMedCentralPubMedCrossRef

20.

Qiao L, MacLean PS, You H et al (2006) Knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice. Endocrinology 147:3060–3069PubMedCrossRef

21.

Qiao L, Kinney B, Yoo HS et al (2012) Adiponectin increases skeletal muscle mitochondrial biogenesis by suppressing mitogen-activated protein kinase phosphatase-1. Diabetes 61:1463–1470PubMedCentralPubMedCrossRef

22.

Qiao L, Zou C, van der Westhuyzen DR, Shao J (2008) Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes 57:1824–1833PubMedCentralPubMedCrossRef

23.

Frezza C, Cipolat S, Scorrano L (2007) Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat Protoc 2:287–295PubMedCrossRef

24.

Yeh T-YJ, Beiswenger KK, Li P et al (2009) Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice. Diabetes 58:2476–2485PubMedCentralPubMedCrossRef

25.

Zechner C, Lai L, Zechner JF et al (2010) Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab 12:633–642PubMedCentralPubMedCrossRef

26.

Tseng Y-H, Kokkotou E, Schulz TJ et al (2008) New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454:1000–1004PubMedCentralPubMedCrossRef

27.

Blaak EE, van Baak MA, Kempen KP, Saris WH (1993) Role of alpha- and beta-adrenoceptors in sympathetically mediated thermogenesis. Am J Physiol 264:E11–E17PubMed

28.

Iwabu M, Yamauchi T, Okada-Iwabu M et al (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464:1313–1319PubMedCrossRef

29.

Civitarese AE, Ukropcova B, Carling S et al (2006) Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab 4:75–87PubMedCentralPubMedCrossRef

30.

Tanner CB, Madsen SR, Hallowell DM et al (2013) Mitochondrial and performance adaptations to exercise training in mice lacking skeletal muscle LKB1. Am J Physiol Endocrinol Metab 305:E1018–E1029PubMedCrossRef

31.

Leick L, Wojtaszewski JFP, Johansen ST et al (2008) PGC-1alpha is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab 294:E463–E474PubMedCrossRef

32.

Yamauchi T, Kamon J, Ito Y et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762–769PubMedCrossRef

33.

Chao P-T, Yang L, Aja S et al (2011) Knockdown of NPY expression in the dorsomedial hypothalamus promotes development of brown adipocytes and prevents diet-induced obesity. Cell Metab 13:573–583PubMedCentralPubMedCrossRef

34.

Thureson-Klein A, Mill-Hyde B, Barnard T, Lagercrantz H (1976) Ultrastructural effects of chemical sympathectomy on brown adipose tissue. J Neurocytol 5:677–690PubMedCrossRef

35.

Hug C, Wang J, Ahmad NS et al (2004) T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A 101:10308–10313PubMedCentralPubMedCrossRef

36.

Svensson E, Olsen L, Mörck C et al (2011) The adiponectin receptor homologs in C. elegans promote energy utilization and homeostasis. PLoS ONE 6:e21343PubMedCentralPubMedCrossRef

Title: Adiponectin reduces thermogenesis by inhibiting brown adipose tissue activation in mice
Authors: Liping Qiao
Hyung sun Yoo
Chris Bosco
Bonggi Lee
Gen-Sheng Feng
Jerome Schaack
Nai-Wen Chi
Jianhua Shao
Publication date: 01-05-2014
Publisher: Springer Berlin Heidelberg
Published in: Diabetologia / Issue 5/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-014-3180-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Adiponectin reduces thermogenesis by inhibiting brown adipose tissue activation in mice

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Aims/hypothesis

Methods

Results

Conclusions/interpretation

Please log in to get access to this content

Other articles of this Issue 5/2014

The effect of a single 2 h bout of aerobic exercise on ectopic lipids in skeletal muscle, liver and the myocardium

Self-monitoring of blood glucose: a promise still unfulfilled?

Inhibition of macrophage fatty acid β-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses

In vivo activation of the PI3K–Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetes

Validation of metabolic syndrome score by confirmatory factor analysis in children and adults and prediction of cardiometabolic outcomes in adults

Ezetimibe in the balance: can cholesterol-lowering drugs alone be an effective therapy for NAFLD?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page